| Credo Counseling | |
|
215 Pitkin Ave Ste 102 Grand Junction CO 81501-7805 | |
| (970) 986-8668 | |
| (970) 986-8586 |
| Full Name | Credo Counseling |
|---|---|
| Speciality | Counselor |
| Location | 215 Pitkin Ave Ste 102, Grand Junction, Colorado |
| Authorized Official Name and Position | Carleen Michelle Bryant (CLINICAL THERAPIST) |
| Authorized Official Contact | 9709868668 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Credo Counseling 215 Pitkin Ave Ste 102 Grand Junction CO 81501-7805 Ph: (970) 986-8668 | Credo Counseling 215 Pitkin Ave Ste 102 Grand Junction CO 81501-7805 Ph: (970) 986-8668 |
| NPI Number | 1013302074 |
|---|---|
| Provider Enumeration Date | 04/06/2015 |
| Last Update Date | 02/20/2024 |
| Certification Date | 02/20/2024 |
| Medicare PECOS PAC ID | 8527374222 |
|---|---|
| Medicare Enrollment ID | O20230211000275 |
News Archive
The use of metals in drug delivery could offer major benefits, including allowing for lower dosages of a medication to achieve therapeutic effects.
The developmental period from adolescence to adulthood is accompanied by a greater vulnerability to addictions – including alcohol use disorders – than is seen in other periods of life.
The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013302074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 2182 (South Dakota) | Primary |
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
| Provider Name | Claire Bryant |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1134737034 PECOS PAC ID: 0244602605 Enrollment ID: I20230211000336 |
News Archive
The use of metals in drug delivery could offer major benefits, including allowing for lower dosages of a medication to achieve therapeutic effects.
The developmental period from adolescence to adulthood is accompanied by a greater vulnerability to addictions – including alcohol use disorders – than is seen in other periods of life.
The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.
› Verified 6 days ago
News Archive
The use of metals in drug delivery could offer major benefits, including allowing for lower dosages of a medication to achieve therapeutic effects.
The developmental period from adolescence to adulthood is accompanied by a greater vulnerability to addictions – including alcohol use disorders – than is seen in other periods of life.
The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.
Experts at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) are joining colleagues across the globe this week to promote prudent use of antibiotics.
CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.
› Verified 6 days ago
Psychodynamics Professional Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2501 Blichmann Avenue, Suite 115, Grand Junction, CO 81505 Phone: 970-255-7672 | |
Inner Journey Community Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 735 South Ave, Grand Junction, CO 81501 Phone: 970-242-1433 Fax: 970-241-4379 | |
Psychological Associates Of Western Co. P.c. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2530 North 8th Street, Suite #204, Grand Junction, CO 81501 Phone: 970-245-3505 Fax: 970-245-1766 | |
Mind Springs, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 515 28 3/4 Rd, Grand Junction, CO 81501 Phone: 970-241-6023 | |
Sojourners Psychological Services, Ltd. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 951 Main Street, Grand Junction, CO 81501 Phone: 970-985-8161 Fax: 970-248-9006 | |
Caprock Behavioral Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 389 Roberts Court, Grand Junction, CO 81504 Phone: 970-243-8220 Fax: 970-243-1511 |